-
Mashup Score: 19
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 19
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 18In Memoriam: George L. Bakris, MD (1952 to 2024) | Hypertension - 10 day(s) ago
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 18In Memoriam: George L. Bakris, MD (1952 to 2024) | Hypertension - 23 day(s) ago
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 18In Memoriam: George L. Bakris, MD (1952 to 2024) | Hypertension - 24 day(s) ago
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 14In Memoriam: George L. Bakris, MD (1952 to 2024) | Hypertension - 25 day(s) ago
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 461
Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy / Approximately half of all people living with heart failure (HF) have HF with mildly reduced or preserved left ventricular ejection fraction (LVEF), i.e. a LVEF of ≥40%, h…
Source: www.bayer.comCategories: General Medicine News, CardiologistsTweet-
*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside @scottdsolomon @PSJhund https://t.co/RHM58WTYbq https://t.co/PhIwUYapU7
-
-
Mashup Score: 451
Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy / Approximately half of all people living with heart failure (HF) have HF with mildly reduced or preserved left ventricular ejection fraction (LVEF), i.e. a LVEF of ≥40%, h…
Source: www.bayer.comCategories: General Medicine News, CardiologistsTweet-
*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside @scottdsolomon @PSJhund https://t.co/RHM58WTYbq https://t.co/PhIwUYapU7
-
-
Mashup Score: 449
Finerenone significantly reduced the composite of cardiovascular death and total (first and recurrent) heart failure events compared to placebo in addition to usual therapy / Approximately half of all people living with heart failure (HF) have HF with mildly reduced or preserved left ventricular ejection fraction (LVEF), i.e. a LVEF of ≥40%, h…
Source: www.bayer.comCategories: General Medicine News, CardiologistsTweet-
*Breaking* P3 #FINEARTSHF meets its primary endpoint (CVd+total HF events)! Non-steroidal MRA finerenone "demonstrates definitive CV benefits" in HFmrEF & HFpEF Looking forward to presenting full results at #ESCCongress alongside @scottdsolomon @PSJhund https://t.co/RHM58WTYbq https://t.co/PhIwUYapU7
-
-
Mashup Score: 14Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: Rationale and design of the FINEARTS‐HF trial - 1 month(s) ago
European Journal of Heart Failure is an ESC journal dedicated to improving the understanding, prevention, investigation and treatment of heart failure.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
#FINEARTSHF Design Published in #EJHF Non-steroidal #MRA finerenone was specifically designed to optimize cardio-kidney protection, while mitigating risks of hyperkalemia Builds on a strong P2/3 RCT portfolio, incl comparative data versus steroidal MRAs https://t.co/uDTa7omfny https://t.co/e1ahoyHmwq
-
RT @AgarwalRajivMD: Matt Weir & I offer an obituary of our affable colleage George Bakris https://t.co/J7rSgdm2Fy "With a diagnosis of canc…